Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Placenta. 2011 Oct 20;32(12):975–980. doi: 10.1016/j.placenta.2011.09.015

Figure 1.

Figure 1

ADAM17 expression in normal and preeclamptic placentas. A: Representative ADAM17 immunostaining in normal and preeclamptic (PE) placentas. ADAM17 immunostaining is mainly localized in the syncytiotrophoblasts in placental villous tissue. Intensive ADAM17 immunostaining is shown in placentas from women with PE compared to those from normal pregnant controls. Bar = 50 micron. B: mRNA and protein expressions for ADAM17 in normal and preeclamptic placentas. Protein expression, but not mRNA, of ADAM17 is increased in preeclamptic placentas.